End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.71 CNY | -0.25% | -0.32% | -1.87% |
01-08 | Yiling Pharma Withdraws Plans to Trial Assisted Reproductive Drug | MT |
12-02 | Yiling Pharmaceutical Unit Gets Nod to Market Simvastatin Tablets in US | MT |
Evolution of the Average Target: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Evolution of the Target Price: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Changes in Analyst Recommendations: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+28.01% | ||||||
+24.39% | ||||||
+14.91% | ||||||
- | - | - | ||||
+38.48% | ||||||
- | - | +7.82% | ||||
- | - | +50.92% | ||||
Average | +27.42% | |||||
Weighted average by Cap. | +25.68% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002603 Stock
- Consensus Shijiazhuang Yiling Pharmaceutical Co., Ltd.
MarketScreener is also available in this country: United States.
Switch edition